Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Promise and Potential of “Organs-on-Chips” as Preclinical Models

The Promise and Potential of “Organs-on-Chips” as Preclinical Models APPLIED IN VITRO TOXICOLOGY ROUNDTABLE DISCUSSION Volume 1, Number 4, 2015 ª Mary Ann Liebert, Inc. DOI: 10.1089/aivt.2015.29002.rtl The Promise and Potential of ‘‘Organs-on-Chips’’ as Preclinical Models Moderator: Anthony Bahinski, PhD, MBA, FAHA 2 3 4 Participants: Reyk Horland, PhD, Dan Huh, PhD, Christine Mummery, PhD, 5 6,* Danilo A. Tagle, PhD, and Tracy MacGill, PhD Introduction channels are perfused with culture medium to provide cells with nutrients, oxygen, and other soluble factors critical for evelopment of safe and effective drugs is currently cell growth and differentiation. Dhampered by the poor predictive power of existing pre- Virtually, all human organs consist of multiple types of clinical animal models that often lead to failure of drug com- tissue and they self-assemble into various patterns to create pounds late in their development. This roundtable brings interesting 3D structures and microarchitecture in a very together experts in the field of microphysiological systems, organ-specific manner. One of the key design requirements stem cell biology, as well as governmental and regulatory for human organ-chip devices is to mimic these organ- thought leaders to discuss the development and potential util- specific tissue structures and biological interfaces between ity of human ‘‘organs-on-chips’’ as preclinical models for http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied In Vitro Toxicology Mary Ann Liebert

The Promise and Potential of “Organs-on-Chips” as Preclinical Models

The Promise and Potential of “Organs-on-Chips” as Preclinical Models

Applied In Vitro Toxicology , Volume 1 (4): 8 – Dec 1, 2015

Abstract

APPLIED IN VITRO TOXICOLOGY ROUNDTABLE DISCUSSION Volume 1, Number 4, 2015 ª Mary Ann Liebert, Inc. DOI: 10.1089/aivt.2015.29002.rtl The Promise and Potential of ‘‘Organs-on-Chips’’ as Preclinical Models Moderator: Anthony Bahinski, PhD, MBA, FAHA 2 3 4 Participants: Reyk Horland, PhD, Dan Huh, PhD, Christine Mummery, PhD, 5 6,* Danilo A. Tagle, PhD, and Tracy MacGill, PhD Introduction channels are perfused with culture medium to provide cells with nutrients, oxygen, and other soluble factors critical for evelopment of safe and effective drugs is currently cell growth and differentiation. Dhampered by the poor predictive power of existing pre- Virtually, all human organs consist of multiple types of clinical animal models that often lead to failure of drug com- tissue and they self-assemble into various patterns to create pounds late in their development. This roundtable brings interesting 3D structures and microarchitecture in a very together experts in the field of microphysiological systems, organ-specific manner. One of the key design requirements stem cell biology, as well as governmental and regulatory for human organ-chip devices is to mimic these organ- thought leaders to discuss the development and potential util- specific tissue structures and biological interfaces between ity of human ‘‘organs-on-chips’’ as preclinical models for

Loading next page...
 
/lp/mary-ann-liebert/the-promise-and-potential-of-organs-on-chips-as-preclinical-models-hev2NuacLb
Publisher
Mary Ann Liebert
Copyright
Copyright 2015, Mary Ann Liebert, Inc.
ISSN
2332-1512
eISSN
2332-1539
DOI
10.1089/aivt.2015.29002.rtl
Publisher site
See Article on Publisher Site

Abstract

APPLIED IN VITRO TOXICOLOGY ROUNDTABLE DISCUSSION Volume 1, Number 4, 2015 ª Mary Ann Liebert, Inc. DOI: 10.1089/aivt.2015.29002.rtl The Promise and Potential of ‘‘Organs-on-Chips’’ as Preclinical Models Moderator: Anthony Bahinski, PhD, MBA, FAHA 2 3 4 Participants: Reyk Horland, PhD, Dan Huh, PhD, Christine Mummery, PhD, 5 6,* Danilo A. Tagle, PhD, and Tracy MacGill, PhD Introduction channels are perfused with culture medium to provide cells with nutrients, oxygen, and other soluble factors critical for evelopment of safe and effective drugs is currently cell growth and differentiation. Dhampered by the poor predictive power of existing pre- Virtually, all human organs consist of multiple types of clinical animal models that often lead to failure of drug com- tissue and they self-assemble into various patterns to create pounds late in their development. This roundtable brings interesting 3D structures and microarchitecture in a very together experts in the field of microphysiological systems, organ-specific manner. One of the key design requirements stem cell biology, as well as governmental and regulatory for human organ-chip devices is to mimic these organ- thought leaders to discuss the development and potential util- specific tissue structures and biological interfaces between ity of human ‘‘organs-on-chips’’ as preclinical models for

Journal

Applied In Vitro ToxicologyMary Ann Liebert

Published: Dec 1, 2015

There are no references for this article.